Latest Als News

Alara Resources' joint venture in Oman is under legal scrutiny as local residents seek to halt operations and challenge project licences. The company disputes the claims and continues production while monitoring developments.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

Artemis Resources confirms a significant gold-bearing shear zone at Titan East near its Carlow deposit, highlighted by a wide 19m intersection at 1.6g/t Au and a previous high-grade 5m intercept at 13.1g/t Au. Diamond drilling has commenced to better define this emerging gold system.

Battery Age Minerals has wrapped up its 2025 drilling campaigns at two strategically important projects in Argentina and Austria, setting the stage for assay results that will guide exploration in 2026.

Exultant Mining has launched an aggressive exploration campaign at its Black Hammer Project in New South Wales, collecting 76 rock chip samples and expanding its tenure with a newly granted exploration licence. The company is progressing land access agreements and plans to commence drilling in early 2026.

Cosmo Metals has reported promising results from its maiden drilling at the Spring Creek prospect, confirming continuity of high-grade gold mineralisation and identifying new target zones along a major regional trend.

Asian Battery Metals PLC reports outstanding metallurgical test results from its Oval Cu-Ni-PGE project in Mongolia, confirming high copper recoveries of up to 95% with a simple flotation process and no penalty elements. Nickel concentrate optimization is underway, supporting the project's development trajectory.

Rimfire Pacific Mining has completed a 23-hole air core drilling campaign at its Rabbit Trap Scandium Project in NSW, intersecting promising rock types at the Malamute Prospect. Assay results expected in January 2026 will clarify the discovery’s potential.

Exultant Mining has completed key reconnaissance work at its Peak View Project in New South Wales, collecting 16 rock chip samples from historic prospects and securing land access agreements ahead of a planned drilling campaign in 2026.

New Frontier Minerals is wrapping up its first reverse circulation drilling at Harts Range, with samples now en route for assay analysis. Meanwhile, progress at the Big One Deposit mining lease signals advancing copper ambitions.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.